BrightSpring Health Services, Inc. Common Stock (BTSG) Q2 FY26 Earnings Call

Strong growth and deleveraging support raised guidance, but IRA headwinds remain a material pharmacy overhang.

Q2 FY26 results, source: company transcript and SEC filings
QuarterQ2 FY26
Call date2026-07-31
Length60 minutes
EPS$0.45
EPS consensus$0.37
Revenue$3.9B

What changed, guidance prior to now, analyst Q&A candor and the case for and against are part of Core.

Other quarters: Q4 FY25 · Q2 FY25

All BTSG earnings · Back to BTSG overview

Transcript produced by Signals.AI from the company's own earnings call audio. Not personalized investment advice.